HMC

Harvard Management Company Portfolio holdings

AUM $1.44B
This Quarter Return
-5.99%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$1.79B
AUM Growth
+$1.79B
Cap. Flow
+$79.8M
Cap. Flow %
4.46%
Top 10 Hldgs %
81.39%
Holding
42
New
12
Increased
7
Reduced
8
Closed
4

Sector Composition

1 Healthcare 44.96%
2 Technology 21.24%
3 Financials 12.87%
4 Communication Services 7.46%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PDD icon
26
Pinduoduo
PDD
$177B
$5.69M 0.32%
+42,490
New +$5.69M
IJR icon
27
iShares Core S&P Small-Cap ETF
IJR
$84.4B
$5.46M 0.31%
50,304
+594
+1% +$64.5K
NCNA
28
NuCana
NCNA
$5.8M
$4.95M 0.28%
198
-138
-41% -$3.45M
FULC icon
29
Fulcrum Therapeutics
FULC
$353M
$4.84M 0.27%
410,714
IJH icon
30
iShares Core S&P Mid-Cap ETF
IJH
$99.4B
$4.2M 0.23%
80,645
-630
-0.8% -$32.8K
VWO icon
31
Vanguard FTSE Emerging Markets ETF
VWO
$96.5B
$4.19M 0.23%
80,501
+141
+0.2% +$7.34K
PRDS
32
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$3.98M 0.22%
+400,000
New +$3.98M
DNTH icon
33
Dianthus Therapeutics
DNTH
$781M
$3.94M 0.22%
20,788
DBTX
34
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$3.74M 0.21%
+328,798
New +$3.74M
IRON icon
35
Disc Medicine
IRON
$2.14B
$3.39M 0.19%
+8,333
New +$3.39M
MCRB icon
36
Seres Therapeutics
MCRB
$162M
$2.72M 0.15%
6,592
DYN icon
37
Dyne Therapeutics
DYN
$1.92B
$1.67M 0.09%
107,252
DADA
38
DELISTED
Dada Nexus
DADA
$1.35M 0.08%
+49,887
New +$1.35M
CG icon
39
Carlyle Group
CG
$22.9B
-23,600
Closed -$742K
PGNY icon
40
Progyny
PGNY
$2.02B
-3,755
Closed -$159K
TWLO icon
41
Twilio
TWLO
$16.1B
-2,021
Closed -$684K
FSDC
42
DELISTED
FS Development Corp. Class A Common Stock
FSDC
-250,000
Closed -$2.75M